Search Within

Takuo Hayashi

Formats
  1. Journal Article (6)
  2. Meeting Abstract (2)
Groups
  1. Department of Pathology and Laboratory Medicine (8)
  2. GSK Faculty (8)
  3. Human Oncology and Pathogenesis Program (8)
  4. Sloan Kettering Institute Postdocs (8)
  5. Tow Center for Developmental Oncology (TCDO) (8)
  6. Department of Medicine (7)

More Groups

People
  1. Marc Ladanyi (8)
  2. Roger Smith (7)
  3. Romel Somwar (7)
  4. Alexander Drilon (5)
  5. Elisa De Stanchina (4)
  6. Gregory Riely (3)

More People

Years
  1. 2024 (2)
  2. 2022 (1)
  3. 2021 (1)
  4. 2018 (1)
  5. 2017 (2)
  6. 2016 (1)
Publications
  1. Clinical Cancer Research (2)
  2. Disease Models & Mechanisms (2)
  3. Journal of Clinical Oncology (2)
  4. JCO Precision Oncology (1)
  5. Oncogene (1)
Publishers
  1. American Society of Clinical Oncology (3)
  2. American Association for Cancer Research (2)
  3. Company of Biologists (2)
  4. Nature Publishing Group (1)

Results (8)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Combination of MDM2 and targeted kinase inhibitors results in prolonged tumor control in lung adenocarcinomas with oncogenic tyrosine kinase drivers and MDM2 amplification
    Journal Article

    Elkrief, A.; Odintsov, I.; Smith, R. S.; Vojnic, M.; Hayashi, T.; Khodos, I.; Markov, V.; Liu, Z.; Lui, A. J. W.; Bloom, J. L.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • The BAP1 nuclear deubiquitinase is involved in the nonhomologous end-joining pathway of double-strand DNA repair through interaction with DNA-PK
    Journal Article

    Sato, H.; Ito, T.; Hayashi, T.; Kitano, S.; Erdjument-Bromage, H.; Bott, M. J.; Toyooka, S.; Zauderer, M.; Ladanyi, M.
    Oncogene (2024)

    Fulltext@MSK | Save
  • Novel patient-derived models of desmoplastic small round cell tumor confirm a targetable dependency on ERBB signaling
    Journal Article

    Smith, R. S.; Odintsov, I.; Liu, Z.; Lui, A. J. W.; Hayashi, T.; Vojnic, M.; Suehara, Y.; Delasos, L.; Mattar, M. S.; Hmeljak, J.; more...
    Disease Models & Mechanisms (2022)

    Fulltext@MSK | Save
  • RET inhibition in novel patient-derived models of RET fusion-positive lung adenocarcinoma reveals a role for MYC upregulation
    Journal Article

    Hayashi, T.; Odintsov, I.; Smith, R. S.; Ishizawa, K.; Liu, A. J. W.; Delasos, L.; Kurzatkowski, C.; Tai, H.; Gladstone, E.; Vojnic, M.; more...
    Disease Models & Mechanisms (2021)

    Fulltext@MSK | Save
  • RASA1 and NF1 are preferentially co-mutated and define a distinct genetic subset of smoking-associated non–small cell lung carcinomas sensitive to MEK inhibition
    Journal Article

    Hayashi, T.; Desmeules, P.; Smith, R. S.; Drilon, A.; Somwar, R.; Ladanyi, M.
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • RASA1 and NF1 co-mutated non-small cell lung carcinomas: Cancer genomic data and evaluation of sensitivity to MEK inhibition
    Meeting Abstract

    Hayashi, T.; Desmeules, P.; Smith, R.; Drilon, A. E.; Somwar, R.; Ladanyi, M.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Antitumor activity of RXDX-105 in multiple cancer types with RET rearrangements or mutations
    Journal Article

    Li, G. G.; Somwar, R.; Joseph, J.; Smith, R. S.; Hayashi, T.; Martin, L.; Franovic, A.; Schairer, A.; Martin, E.; Riely, G. J.; more...
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save
  • MDM2 amplification (Amp) to mediate cabozantinib resistance in patients (Pts) with advanced RET-rearranged lung cancers
    Meeting Abstract

    Somwar, R.; Smith, R.; Hayashi, T.; Ishizawa, K.; Charen, A. S.; Khodos, I.; Mattar, M.; He, J.; Balasubramanian, S.; Stephens, P.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save